Chlorogenic Acid for Health & Longevity - Quick Reference Sheet

Chlorogenic Acid for Health & Longevity

Created on 06/20/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Chlorogenic acid, the main antioxidant in coffee and green coffee bean extract, modestly lowers blood pressure, body weight, waist size, and fasting blood sugar — effects that are real but small. The most dramatic weight-loss claims trace to discredited marketing. Generally well-tolerated and low-cost, it offers limited metabolic upside rather than a proven longevity path. (Full Review)

Protocol

Dose
400–800 mg/day
Chlorogenic acid, often 200–400 mg per dose; ≥500 mg/day in weight trials
Timing
Before meals
Favored for glucose-blunting; caffeinated extracts earlier in the day
Schedule
Split into two doses
E.g. before breakfast and dinner, due to biphasic absorption
Time to effect
Blood pressure
4–12 weeks
Consistent use; little effect under 4 weeks
Fasting glucose
4–12 weeks
Emerges with consistent use
Weight & waist
8–12 weeks
Small reductions over the trial period

Benefits

Contraindications
  • Poorly controlled cardiac arrhythmia (caffeinated forms)
  • Pregnancy or breastfeeding
  • Significant anxiety disorders
  • Elevated homocysteine or established cardiovascular disease (high-dose forms)
Key Interactions
  • Antihypertensive drugs (ACE inhibitors, ARBs, calcium channel blockers)
  • Glucose-lowering drugs (metformin, sulfonylureas, insulin)
  • Other blood-pressure-lowering supplements (beetroot/nitrate, garlic extract, magnesium, CoQ10)
  • Stimulants and caffeine sources (coffee, energy drinks, OTC stimulants)
  • Iron and certain minerals

Risk & Side Effects

  • High: Gastrointestinal upset
  • Medium: Caffeine-related effects from green coffee extract; elevated plasma homocysteine
  • Low: Headache
  • Speculative: Bone and mineral concerns; hypersensitivity reactions

Monitoring

Marker Target Why
Blood pressure <120/80 mmHg Primary measurable benefit
Fasting blood glucose 75–90 mg/dL Captures glucose-lowering effect
Fasting insulin 2–6 µIU/mL Detects insulin-sensitizing effect
HbA1c <5.4% 3-month average blood-sugar control
Lipid panel (total cholesterol, LDL, HDL, triglycerides) TC <180; LDL <100; HDL >50; TG <90 mg/dL Detects modest lipid effects
Homocysteine <8 µmol/L Flags chlorogenic acid's homocysteine-raising effect

Cadence: Baseline, then at 6–12 weeks, and every 6–12 months during continued use

Qualitative Assessment

  • Energy levels and any jitteriness or restlessness
  • Sleep quality and time to fall asleep
  • Digestive comfort (nausea, stool changes)
  • Appetite and any change in waist fit of clothing